Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma
Clinical trial NCT03502746 · TERMINATED
Trial details
- NCT number
- NCT03502746
- Sponsor
- Arkadiusz Z. Dudek, MD
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-26
- Primary completion
- 2022-05-11
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.